{"DataElement":{"publicId":"4386312","version":"1","preferredName":"ALK Gene Rearrangement Finding Indicator","preferredDefinition":"the indicator related to ALK rearrangement findings","longName":"ALK_REARRANGE","context":"ECOG-ACRIN","contextVersion":"1","DataElementConcept":{"publicId":"4386273","version":"1","preferredName":"ALK Gene Rearrangement Finding","preferredDefinition":"ALK tyrosine kinase receptor (1620 aa, ~176 kDa) is encoded by the human ALK gene. This protein is involved in ligand binding, tyrosine phosphorylation and signal transduction._Any DNA sequence rearrangement that results in the creation of a novel protein-coding capacity. Within certain genes, gene rearrangement is a normal part of development, facilitating the affinity maturation of B and T lymphocytes as well as class switching of immunoglobulins._Clinical, laboratory or molecular evidence, or absence of evidence of disease.","longName":"ALK_REARRANGE","context":"ECOG-ACRIN","contextVersion":"1","ObjectClass":{"publicId":"4386271","version":"1","preferredName":"ALK Tyrosine Kinase Receptor Gene Rearrangement","preferredDefinition":"ALK tyrosine kinase receptor (1620 aa, ~176 kDa) is encoded by the human ALK gene. This protein is involved in ligand binding, tyrosine phosphorylation and signal transduction.:Any DNA sequence rearrangement that results in the creation of a novel protein-coding capacity. Within certain genes, gene rearrangement is a normal part of development, facilitating the affinity maturation of B and T lymphocytes as well as class switching of immunoglobulins.","longName":"C27032:C16611","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ALK Tyrosine Kinase Receptor","conceptCode":"C27032","definition":"ALK tyrosine kinase receptor (1620 aa, ~176 kDa) is encoded by the human ALK gene. This protein is involved in ligand binding, tyrosine phosphorylation and signal transduction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Gene Rearrangement Process","conceptCode":"C16611","definition":"Any DNA sequence rearrangement that results in the creation of a novel protein-coding capacity. Within certain genes, gene rearrangement is a normal part of development, facilitating the affinity maturation of B and T lymphocytes as well as class switching of immunoglobulins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE53E897-374E-4A1A-E040-BB89AD436AA9","latestVersionIndicator":"Yes","beginDate":"2014-07-16","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-07-16","modifiedBy":"ONEDATA","dateModified":"2014-07-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2241301","version":"1","preferredName":"Finding","preferredDefinition":"Clinical manifestations that can be either objective when observed by a physician, or subjective when perceived by the patient.","longName":"C3367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Finding","conceptCode":"C3367","definition":"Clinical, laboratory or molecular evidence, or absence of evidence of disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FAB2D8EC-6E04-68CB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-08","modifiedBy":"ONEDATA","dateModified":"2005-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE53E897-375C-4A1A-E040-BB89AD436AA9","latestVersionIndicator":"Yes","beginDate":"2014-07-16","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-07-16","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4386293","version":"1","preferredName":"Rearrangement Indicator","preferredDefinition":"The Value Domain to indicate a question related to DNA sequence rearrangement with permissible values of yes/no/test failure.","longName":"REARRNGE_IND","context":"ECOG-ACRIN","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FE541964-2840-347B-E040-BB89AD431B98","beginDate":"2012-06-27","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-07-16","modifiedBy":"ONEDATA","dateModified":"2014-07-16","deletedIndicator":"No"},{"value":"Test Failure","valueDescription":"Test Failure","ValueMeaning":{"publicId":"4386294","version":"1","preferredName":"Test Failure","longName":"4386294","preferredDefinition":"Test Failure","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE541964-281D-347B-E040-BB89AD431B98","latestVersionIndicator":"Yes","beginDate":"2014-07-16","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-07-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FE541964-2836-347B-E040-BB89AD431B98","beginDate":"2014-07-16","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-07-16","modifiedBy":"ONEDATA","dateModified":"2014-07-16","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FE541964-284A-347B-E040-BB89AD431B98","beginDate":"2012-06-27","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-07-16","modifiedBy":"ONEDATA","dateModified":"2014-07-16","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4386292","version":"1","preferredName":"DNA Sequence Rearrangement Indicator","preferredDefinition":"Any process affecting a DNA sequence that results in the gain, loss or exchange of DNA between chromosomes and/or autonomous replicons.:An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"C21069:C25180","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"DNA Sequence Rearrangement","conceptCode":"C21069","definition":"Any process affecting a DNA sequence that results in the gain, loss or exchange of DNA between chromosomes and/or autonomous replicons.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Indicator","conceptCode":"C25180","definition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE541964-27FA-347B-E040-BB89AD431B98","latestVersionIndicator":"Yes","beginDate":"2014-07-16","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-07-16","modifiedBy":"ONEDATA","dateModified":"2014-07-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE541964-280B-347B-E040-BB89AD431B98","latestVersionIndicator":"Yes","beginDate":"2014-07-16","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-07-16","modifiedBy":"ROUILLAS","dateModified":"2014-08-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5506111","version":"1","longName":"Lung","context":"MCL","ClassificationSchemeItems":[{"publicId":"5506169","version":"1","longName":"Lung-Vanderbilt","context":"MCL"},{"publicId":"5506172","version":"1","longName":"Clinical","context":"MCL"}]},{"publicId":"5506115","version":"1","longName":"Imaging","context":"MCL","ClassificationSchemeItems":[{"publicId":"5983666","version":"1","longName":"Vanderbilt Image Archive","context":"MCL"}]}],"AlternateNames":[{"name":"MCL","type":"USED_BY","context":"MCL"}],"ReferenceDocuments":[{"name":"Was ALK rearrangement found?","type":"Preferred Question Text","description":"Was ALK rearrangement found?","url":null,"context":"ECOG-ACRIN"},{"name":"MCL-Lung-1","type":"Alternate Question Text","description":"ALK rearrangement on primary tumor","url":null,"context":"MCL"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE541964-2879-347B-E040-BB89AD431B98","latestVersionIndicator":"Yes","beginDate":"2014-07-16","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-07-16","modifiedBy":"COLBERTM","dateModified":"2019-11-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}